SEARCH

SEARCH BY CITATION

References

  • 1
    Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 74454.
  • 2
    Smith EM,Ritchie JM,Summersgill KF,Hoffman HT,Wang DH,Haugen TH,Turek LP. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004; 96: 44955.
  • 3
    Hansson BG,Rosenquist K,Antonsson A,Wennerberg J,Schildt EB,Bladstrom A,Andersson G. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125: 133744.
  • 4
    Mork J,Lie AK,Glattre E,Hallmans G,Jellum E,Koskela P,Moller B,Pukkala E,Schiller JT,Youngman L,Lehtinen M,Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 112531.
  • 5
    Kurose K,Terai M,Soedarsono N,Rabello D,Nakajima Y,Burk RD,Takagi M. Low prevalence of HPV infection and its natural history in normal oral mucosa among volunteers on Miyako Island, Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 916.
  • 6
    Rintala M,Grenman S,Puranen M,Syrjanen S. Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV family study. J Clin Virol 2006; 35: 8994.
  • 7
    D'Souza G,Sugar E,Ruby W,Gravitt P,Gillison M. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J Clin Microbiol 2005; 43: 552635.
  • 8
    Barkan SE,Melnick SL,Preston-Martin S,Weber K,Kalish LA,Miotti P,Young M,Greenblatt R,Sacks H,Feldman J.The Women's Interagency HIV Study. WIHS collaborative study group. Epidemiology 1998; 9: 11725.
  • 9
    Kreimer AR,Alberg AJ,Daniel R,Gravitt PE,Viscidi R,Garrett ES,Shah KV,Gillison ML. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189: 68698.
  • 10
    Coutlee F,Trottier AM,Ghattas G,Leduc R,Toma E,Sanche G,Rodrigues I,Turmel B,Allaire G,Ghadirian P. Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis 1997; 24: 2331.
  • 11
    Fakhry C,D'Souza G,Sugar E,Weber K,Goshu E,Minkoff H,Wright R,Seaberg E,Gillison M. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol 2006; 44: 447985.
  • 12
    Gravitt PE,Peyton CL,Alessi TQ,Wheeler CM,Coutlee F,Hildesheim A,Schiffman MH,Scott DR,Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 35761.
  • 13
    Gravitt PE,Lacey JV,Jr,Brinton LA,Barnes WA,Kornegay JR,Greenberg MD,Greene SM,Hadjimichael OC,McGowan L,Mortel R,Schwartz PE,Zaino R, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001; 10: 95100.
  • 14
    Peyton CL,Gravitt PE,Hunt WC,Hundley RS,Zhao M,Apple RJ,Wheeler CM. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183: 155464.
  • 15
    Kirstein LM,Greenblatt RM,Anastos K,Levine A,French AL,Minkoff H,Silver S,Gange SJ. Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV study. J Acquir Immune Defic Syndr 2002; 29: 495503.
  • 16
    Munoz N,Bosch FX,de Sanjose S,Herrero R,Castellsague X,Shah KV,Snijders PJ,Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 51827.
  • 17
    Kreimer AR,Clifford GM,Boyle P,Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 46775.
  • 18
    Minkoff H,Feldman J,DeHovitz J,Landesman S,Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998; 178: 9826.
  • 19
    Strickler HD,Palefsky JM,Shah KV,Anastos K,Klein RS,Minkoff H,Duerr A,Massad LS,Celentano DD,Hall C,Fazzari M,Cu-Uvin S, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003; 95: 106271.
  • 20
    Sun XW,Kuhn L,Ellerbrock TV,Chiasson MA,Bush TJ,Wright TC,Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 13439.
  • 21
    Ahdieh L,Klein RS,Burk R,Cu-Uvin S,Schuman P,Duerr A,Safaeian M,Astemborski J,Daniel R,Shah K. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001; 184: 68290.
  • 22
    Ahdieh L,Munoz A,Vlahov D,Trimble CL,Timpson LA,Shah K. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 2000; 151: 114857.
  • 23
    Palefsky JM,Minkoff H,Kalish LA,Levine A,Sacks HS,Garcia P,Young M,Melnick S,Miotti P,Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91: 22636.
  • 24
    Strickler HD,Burk RD,Fazzari M,Anastos K,Minkoff H,Massad LS,Hall C,Bacon M,Levine AM,Watts DH,Silverberg MJ,Xue X, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97: 57786.
  • 25
    Lillo FB,Ferrari D,Veglia F,Origoni M,Grasso MA,Lodini S,Mastrorilli E,Taccagni G,Lazzarin A,Uberti-Foppa C. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184: 54751.
  • 26
    McIntyre-Seltman K,Castle PE,Guido R,Schiffman M,Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005; 14: 116570.
  • 27
    Deacon JM,Evans CD,Yule R,Desai M,Binns W,Taylor C,Peto J. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000; 83: 156572.
  • 28
    Castle PE,Wacholder S,Lorincz AT,Scott DR,Sherman ME,Glass AG,Rush BB,Schussler JE,Schiffman M. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002; 94: 140614.
  • 29
    Roteli-Martins CM,Panetta K,Alves VA,Siqueira SA,Syrjanen KJ,Derchain SF. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand 1998; 77: 67882.
  • 30
    Wang SS,Schiffman M,Shields TS,Herrero R,Hildesheim A,Bratti MC,Sherman ME,Rodriguez AC,Castle PE,Morales J,Alfaro M,Wright T, et al. Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Br J Cancer 2003; 89: 124854.
  • 31
    Baseman JG,Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 ( Suppl 1): S16S24.
  • 32
    Giuliano AR,Sedjo RL,Roe DJ,Harri R,Baldwi S,Papenfuss MR,Abrahamsen M,Inserra P. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control 2002; 13: 83946.
  • 33
    Heard I,Palefsky JM,Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004; 9: 1322.
  • 34
    Greenspan D,Canchola AJ,MacPhail LA,Cheikh B,Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357.
  • 35
    Cameron JE,Mercante D,O'Brien M,Gaffga AM,Leigh JE,Fidel PL,Jr,Hagensee ME. The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis 2005; 32: 7039.
  • 36
    King MD,Reznik DA,O'Daniels CM,Larsen NM,Osterholt D,Blumberg HM. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002; 34: 6418.
  • 37
    Palefsky JM,Holly EA,Efirdc JT,Da Costa M,Jay N,Berry JM,Darragh TM. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. Aids 2005; 19: 140714.
  • 38
    Frisch M,Biggar RJ,Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 150010.
  • 39
    Canadas MP,Bosch FX,Junquera ML,Ejarque M,Font R,Ordonez E,de Sanjose S. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol 2004; 42: 13302.